180 related articles for article (PubMed ID: 28883546)
21. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study.
Segovia-Mendoza M; Jurado R; Mir R; Medina LA; Prado-Garcia H; Garcia-Lopez P
BMC Cancer; 2015 Jan; 15():21. PubMed ID: 25622528
[TBL] [Abstract][Full Text] [Related]
22. PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.
He M; Chao L; You YP
Biochem Cell Biol; 2017 Jun; 95(3):385-393. PubMed ID: 28177767
[TBL] [Abstract][Full Text] [Related]
23. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
24. Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer.
Wang Y; Gao Y; Cheng H; Yang G; Tan W
Biochem Biophys Res Commun; 2015 Oct; 466(3):362-8. PubMed ID: 26361149
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
26. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
[TBL] [Abstract][Full Text] [Related]
27. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
[TBL] [Abstract][Full Text] [Related]
28. 8‑bromo‑7‑methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin‑sensitive and resistant ovarian cancer cells.
Ding Q; Chen Y; Zhang Q; Guo Y; Huang Z; Dai L; Cao S
Mol Med Rep; 2015 Oct; 12(4):5100-8. PubMed ID: 26151347
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.
Kitai H; Ebi H; Tomida S; Floros KV; Kotani H; Adachi Y; Oizumi S; Nishimura M; Faber AC; Yano S
Cancer Discov; 2016 Jul; 6(7):754-69. PubMed ID: 27154822
[TBL] [Abstract][Full Text] [Related]
30. Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1.
Lee YH; Pang SW; Revai Lechtich E; Shah K; Simon SE; Ponnusamy S; Narayanan R; Poh CL; Tan KO
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1751-1764. PubMed ID: 32377840
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
32. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.
Xu S; Fu GB; Tao Z; OuYang J; Kong F; Jiang BH; Wan X; Chen K
Oncotarget; 2015 Sep; 6(28):26457-71. PubMed ID: 26238185
[TBL] [Abstract][Full Text] [Related]
33. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
34. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
35. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
36. EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
Nakagawa T; Takeuchi S; Yamada T; Ebi H; Sano T; Nanjo S; Ishikawa D; Sato M; Hasegawa Y; Sekido Y; Yano S
Cancer Res; 2013 Apr; 73(8):2428-34. PubMed ID: 23382048
[TBL] [Abstract][Full Text] [Related]
37. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
38. Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells.
Zhu K; Chen L; Han X; Wang J; Wang J
Oncol Rep; 2012 Apr; 27(4):1027-34. PubMed ID: 22245869
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Schelch K; Hoda MA; Klikovits T; Münzker J; Ghanim B; Wagner C; Garay T; Laszlo V; Setinek U; Dome B; Filipits M; Pirker C; Heffeter P; Selzer E; Tovari J; Torok S; Kenessey I; Holzmann K; Grasl-Kraupp B; Marian B; Klepetko W; Berger W; Hegedus B; Grusch M
Am J Respir Crit Care Med; 2014 Oct; 190(7):763-72. PubMed ID: 25188816
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression.
Song KH; Kim SH; Noh KH; Bae HC; Kim JH; Lee HJ; Song J; Kang TH; Kim DW; Oh SJ; Jeon JH; Kim TW
BMB Rep; 2015 Jun; 48(6):330-5. PubMed ID: 25248562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
